Wipfli Financial Advisors’s Capricor Therapeutics CAPR Stock Holding History

Wipfli Financial Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Buy	+4	New	+$20	﹤0.01%	2565

Other funds holding CAPR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wipfli Financial Advisors's CAPR Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Capricor Therapeutics (CAPR) in Q3 2022: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2565 among its holdings.

31 funds tracked by Wall St. Rank hold CAPR as of Q3 2022.

Wipfli Financial Advisors held 4 shares of Capricor Therapeutics worth $0 as of Q3 2022.
Capricor Therapeutics was a new Wipfli Financial Advisors position in Q3 2022.
Capricor Therapeutics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2565 holding.
31 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.